Souhaitez-vous accéder aux communiqués récents ?

New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy,...

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...

NEWARK, Del, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The Lung Cancer Therapeutics Market 2024 to 2034 is expected to experience a substantial increase in size, growing from USD 37.5 billion in 2024 to USD...

New York, United States, Nov. 21, 2024 (GLOBE NEWSWIRE) -- "Liquid biopsy" isolates and detects circulating nucleic acids (DNA or RNA), exosomes, and circulating tumor cells to diagnose primary...

Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates

Vancouver, Nov. 04, 2024 (GLOBE NEWSWIRE) -- November is Radon Action Month, and the BC Real Estate Association (BCREA), BC Lung Foundation, and Real Estate Foundation of BC are announcing the...

Raleigh, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 9, Wake Radiology UNC Health Rex, in partnership with the American College of Radiology, is participating in National Lung...

New treatments and novel research are driving better survival rates for Canadians with Lung Cancer, offering hope to thousands of patients.

TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF), the premier resource on lung health for all Canadians, is urging all Canadians to act on findings presented in the 2024...

– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint inhibitor compared to docetaxel in recurrent...